Constantine E. Anagnostopoulos, Ph.D.
Chairman, MetaPhore Pharmaceuticals, Inc., Deltagen, Inc., & Kereos, Inc.
Dr. Anagnostopoulos is a retired corporate officer of Monsanto Company having served as Science Fellow, director of research, head of its New Enterprise Division, general manager of a number of divisions and as chairman, managering director and CEO of Monsanto Europe-Africa-Middle East. He recently retired as managing director of Gateway Associates, a St. Louis-based venture capital firm, and as the Lead Director of Genzyme Inc. He is presently chairman of two biopharmaceutical companies, Deltagen and Kereos, and sites on the board of three other high technology companies, including MetaPhore Pharmaceuticals.
Dr. Anagnostopoulos holds a doctorate in organic chemistry from Harvard University and over twenty patents in organic and polymer chemistry. He has served on the Presidential Council on Innovation, the Committee on the Patent System, the National Inventors Council and the Industrial Research Institute. He was the first recipient of the Saint Louis Technology Award.